183 related articles for article (PubMed ID: 38245327)
1. Pathogenetic treatments for diabetic peripheral neuropathy.
Ziegler D
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
[TBL] [Abstract][Full Text] [Related]
2. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in the management of diabetic polyneuropathy.
Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
[TBL] [Abstract][Full Text] [Related]
4. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
5. Burning through the pain: treatments for diabetic neuropathy.
Javed S; Alam U; Malik RA
Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
[TBL] [Abstract][Full Text] [Related]
6. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update.
Rafiullah M; Siddiqui K
CNS Neurol Disord Drug Targets; 2022; 21(10):884-900. PubMed ID: 33655879
[TBL] [Abstract][Full Text] [Related]
8. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
10. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of epalrestat plus α-lipoic acid combination therapy
Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734
[TBL] [Abstract][Full Text] [Related]
13. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
14. The Treatment of Painful Diabetic Neuropathy.
Sloan G; Alam U; Selvarajah D; Tesfaye S
Curr Diabetes Rev; 2022; 18(5):e070721194556. PubMed ID: 34238163
[TBL] [Abstract][Full Text] [Related]
15. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diabetic polyneuropathy: Update 2006.
Ziegler D
Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
[TBL] [Abstract][Full Text] [Related]
17. Diabetic painful neuropathy: current and future treatment options.
Chong MS; Hester J
Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
[TBL] [Abstract][Full Text] [Related]
18. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
[TBL] [Abstract][Full Text] [Related]
19. [The clinic, diagnosis, complex treatment of diabetic polyneuropathy].
Terent'eva NV
Lik Sprava; 2012; (7):187-91. PubMed ID: 23350148
[TBL] [Abstract][Full Text] [Related]
20. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
Wang XT; Lin HX; Xu SA; Lu YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
